ArticlePloS one2024
Analyzing and predicting short-term substance use behaviors of persons who use drugs in the great plains of the U.S.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundSubstance use induces large economic and societal costs in the U.S. Understanding the change in substance use behaviors of persons who use drugs (PWUDs) over time, therefore, is important in order to inform healthcare providers, policymakers, and other stakeholders toward more efficient allocation of limited resources to at-risk PWUDs.
objectiveThis study examines the short-term (within a year) behavioral changes in substance use of PWUDs at the population and individual levels.
methods237 PWUDs in the Great Plains of the U.S. were recruited by our team. The sample provides us longitudinal survey data regarding their individual attributes, including drug use behaviors, at two separate time periods spanning 4-12 months. At the population level, we analyze our data quantitatively for 18 illicit drugs; then, at the individual level, we build interpretable machine learning logistic regression and decision tree models for identifying relevant attributes to predict, for a given PWUD, (i) which drug(s) they would likely use and (ii) which drug(s) they would likely increase usage within the next 12 months. All predictive models were evaluated by computing the (averaged) Area under the Receiver Operating Characteristic curve (AUROC) and Area under the Precision-Recall curve (AUPR) on multiple distinct sets of hold-out sample.
resultsAt the population level, the extent of usage change and the number of drugs exhibiting usage changes follow power-law distributions. At the individual level, AUROC's of the models for the top-4 prevalent drugs (marijuana, methamphetamines, amphetamines, and cocaine) range 0.756-0.829 (+2.88-7.66% improvement with respect to baseline models using only current usage of the respective drugs as input) for (i) and 0.670-0.765 (+4.34-18.0%) for (ii). The corresponding AUPR's of the said models range 0.729-0.947 (+2.49-13.6%) for (i) and 0.348-0.618 (+26.9-87.6%) for (ii).
conclusionThe observed qualitative changes in short-term substance usage and the trained predictive models for (i) and (ii) can potentially inform human decision-making toward efficient allocation of appropriate resources to PWUDs at highest risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.